Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Early fee deadline for the Best of ASRM and ESHRE 2025 is fast approaching. Register now!

Bio-economy and the commercialisation of ART 

Precongress Course 6
SIG Global and Sociocultural-Aspects of Infertility SIG Global and Socio-cultural aspects of (in)fertility
Course type

Basic



Course co-ordinators

Willem Ombelet (Belgium), Virginie Rozée (France), Trudie Gerrits (The Netherlands), Françoise Shenfield (United Kingdom)



Course description

The development of ART has been accompanied for many years by growing globalisation and commercialisation. Several aspects include patchy state funding with a public/private disparity and increased competition, the growth of cross border reproductive care, and the compensation or remuneration in “third party” ART whether by gametes donation or surrogacy that creates a kind of new reproductive labour and a parallel bio-economy.

This context raises many issues in terms of accessibility, (in)equalities, risks and benefits both for our patients, third parties involved (donors and surrogates) and policy makers .
The objective of this precongress course is to analyse some issues raised by the commercialisation of ART with specific examples and to discuss some models which might best benefit different patients who need fertility care.



Target audience

Clinicians, nurses, scientists, psychologists, counsellors, social workers, researchers, managers, health care providers.



Educational needs and expected outcomes

To analyse the impact and consequences of commercialisation of reproductive medicine for patients, practitioners, health care providers, health care and society in general. The expected outcome is to critically analyse commercialisation in ART.

 

Programme


Saturday 26 June 2021

Session 1
Chairs
Françoise Shenfield, United Kingdom
Willem Ombelet, Belgium
09:00 - 09:30
Industry and assisted reproduction: Ain't no sunshine
Cindy M. Farquhar, New Zealand
09:30 - 09:45
Discussion
09:45 - 10:15
The financialisation of fertility
Lucy van de Wiel, United Kingdom
10:15 - 10:30
Discussion
10:30 - 11:00
Coffee break
Session 2
Denisa Marina Protopopescu, Romania
Gamal I. Serour, Egypt
11:00 - 11:30
The risks and benefits of add-ons in IVF programmes
Tarek El-Toukhy, United Kingdom
11:30 - 11:45
Discussion
11:45 - 12:15
Introducing affordable IVF: Dreams versus nightmares
Willem Ombelet, Belgium
12:15 - 12:30
Discussion
12:30 - 13:30
Lunch break